Market Outperform Rating Reiterated for Allakos Amid Promising AK006 Clinical Developments
TipRanksApr 24 12:25
Hold Rating on Allakos Amidst Cautious Optimism for AK006 Program
TipRanksMar 19 13:38
Analysts Are Bullish on These Healthcare Stocks: Allakos (ALLK), Century Therapeutics (IPSC)
TipRanksMar 15 19:10
Analysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)
TipRanksMar 15 12:40
TD Cowen Remains a Hold on Allakos (ALLK)
TipRanksMar 15 06:35
Analysts' Top Healthcare Picks: KalVista Pharmaceuticals (KALV), Allakos (ALLK)
TipRanksFeb 27 05:10
Allakos Analyst Ratings
BenzingaJan 18 03:15
Allakos Extends Losses as Analysts Downgrade on Phase 2 Setback
Seeking AlphaJan 18 00:52
JMP Securities Adjusts Allakos' Price Target to $3 From $10, Maintains Market Outperform Rating
MT NewswiresJan 17 20:22
Barclays: Maintaining the Allakos (ALLK.US) holdings reduction rating, the target price was adjusted from $1.50 to $1.00.
Zhitong FinanceJan 17 19:20
Allakos Analyst Ratings
BenzingaJan 17 18:54
Analysts Offer Insights on Healthcare Companies: Allakos (ALLK) and Crinetics Pharmaceuticals (CRNX)
TipRanksDec 19, 2023 20:40
Allakos Analyst Ratings
BenzingaDec 18, 2023 20:06
Jefferies Assumes Allakos at Buy, Lowers Price Target of $6
BenzingaDec 8, 2023 21:59
Allakos Analyst Ratings
BenzingaDec 8, 2023 21:55
JMP Securities Reiterates Market Outperform on Allakos, Maintains $10 Price Target
BenzingaNov 29, 2023 01:26
Allakos Analyst Ratings
BenzingaNov 29, 2023 01:24
Buy Rating for Allakos: Anticipating Lirentelimab's Market Catalyst and Blockbuster Potential
TipRanksNov 28, 2023 13:45
Promising Developments and Solid Financials Drive Buy Rating for Allakos: An Analysis of Lirentelimab Trials and Investment Potential
TipRanksNov 15, 2023 06:55
Barclays Maintains Underweight on Allakos, Lowers Price Target to $1.5
BenzingaNov 14, 2023 20:59
No Data
No Data